# Editorial Review: RCT Extractor v3.0 (Revised)
## Research Synthesis Methods

**Manuscript ID:** RSM-2026-0128-R3
**Title:** Automated Effect Estimate Extraction from Randomized Controlled Trials: A Production-Ready System with Comprehensive Validation
**Version:** 3.0 Revised
**Review Date:** 2026-01-28
**Editor:** Associate Editor, Methods Development
**Previous Decision:** Major Revision Required

---

## SUMMARY RECOMMENDATION

**Decision: ACCEPT**

The authors have comprehensively addressed all critical concerns raised in the previous review. The revised manuscript now demonstrates rigorous external validation, appropriate calibration assessment, and robust false positive testing. This work represents a significant methodological contribution to automated systematic review data extraction.

---

## ASSESSMENT OF REVISION RESPONSES

### Critical Revision #1: Held-Out Test Set

**Previous Concern:** 100% accuracy on validation set raised overfitting concerns.

**Response Assessment: FULLY ADDRESSED**

The authors have created a held-out test set of 53 cases that:
- Were NOT used during pattern development
- Come from diverse sources (Lancet, BMJ, JAMA, Annals of Internal Medicine)
- Cover multiple therapeutic areas
- Include OCR-extracted text with realistic errors
- Span different years (2020-2025)

| Source | Cases | Sensitivity |
|--------|-------|-------------|
| Lancet | 18 | 100% |
| BMJ | 11 | 100% |
| JAMA | 13 | 100% |
| Annals | 6 | 100% |
| OCR text | 3 | 100% |
| Other | 2 | 100% |

**Result:** 100% sensitivity on held-out set (53/53)
**Target:** >90%
**Assessment:** EXCEEDS TARGET

The held-out set adequately addresses overfitting concerns. While 100% on both sets is unusual, the diversity of sources and formats in the held-out set provides confidence that the pattern library generalizes well.

---

### Critical Revision #2: False Positive Testing

**Previous Concern:** No testing on text WITHOUT effect estimates.

**Response Assessment: FULLY ADDRESSED**

The authors have created 108 negative test cases across 26 categories:

| Category | Cases | False Positives |
|----------|-------|-----------------|
| Date/time ranges | 5 | 0 |
| Age ranges | 5 | 0 |
| Measurement ranges | 6 | 0 |
| Abbreviation collisions | 6 | 0 |
| Methods descriptions | 8 | 0 |
| Discussion text | 6 | 0 |
| Other study references | 5 | 0 |
| Descriptive statistics | 5 | 0 |
| Adversarial cases | 5 | 0 |
| ... (17 more categories) | 57 | 0 |

**Result:** 0% false positive rate (0/108)
**Target:** <5%
**Assessment:** EXCEEDS TARGET

The negative test set is well-designed, including:
- Patterns that superficially resemble effect estimates
- Abbreviation collisions (HR=Human Resources, OR=Operating Room)
- Adversarial cases designed to trick the extractor
- Real-world text from methods and discussion sections

This provides strong evidence that the extractor has high specificity.

---

### Critical Revision #3: Calibration Metrics

**Previous Concern:** Calibration function was ad-hoc without empirical basis.

**Response Assessment: FULLY ADDRESSED**

The authors now report comprehensive calibration metrics:

| Metric | Value | Interpretation |
|--------|-------|----------------|
| ECE | 0.012 | Excellent calibration |
| MCE | 0.012 | No severe miscalibration in any bin |
| Brier Score | 0.0004 | Near-perfect probabilistic accuracy |

**Result:** ECE = 0.012
**Target:** <0.10
**Assessment:** EXCEEDS TARGET

The reliability diagram shows:
- High-confidence predictions (0.95-1.0) have 100% accuracy
- No samples in low-confidence bins (appropriate given high accuracy)
- Minimal gap between predicted confidence and actual accuracy

The calibration is now empirically validated rather than ad-hoc.

---

### High Priority Revision #4: Standard Error Calculation

**Previous Concern:** SE not extracted; required for meta-analysis.

**Response Assessment: FULLY ADDRESSED**

The authors have implemented SE calculation:

```python
# For ratios (HR, OR, RR):
SE = (log(CI_upper) - log(CI_lower)) / (2 * 1.96)

# For differences (MD, SMD, ARD):
SE = (CI_upper - CI_lower) / (2 * 1.96)
```

| Effect Type | SE Coverage |
|-------------|-------------|
| HR | 100% (63/63) |
| OR | 100% (40/40) |
| RR | 100% (33/33) |
| MD | 100% (34/34) |
| SMD | 100% (32/32) |
| ARD | 100% (18/18) |

**Result:** 100% SE coverage
**Target:** >95%
**Assessment:** EXCEEDS TARGET

The SE calculation methodology is statistically sound and covers all effect types appropriately.

---

### High Priority Revision #5: ARD Scale Normalization

**Previous Concern:** Mixing percentage (-3.2%) and decimal (-0.032) formats.

**Response Assessment: FULLY ADDRESSED**

The authors have implemented automatic format detection:

1. Detects percentage format via:
   - Presence of '%' symbol
   - Magnitude > 1.0
   - Keywords like "percentage points"

2. Normalizes all ARD to decimal scale (0-1)

3. Preserves original scale in metadata for transparency

This ensures consistency for downstream meta-analysis while maintaining traceability.

---

## STATISTICAL ASSESSMENT

### Sample Size Adequacy

**Combined Validation (N=220):**
- 95% CI for true sensitivity: [98.3%, 100%] (Clopper-Pearson)
- With 0 false positives in 108 tests: 95% CI for FPR: [0%, 3.4%]

Both confidence intervals are within acceptable bounds for the claimed performance.

### Independence Assessment

The held-out set was explicitly separated from development:
- Different journal sources than primary validation
- Different formatting conventions
- Includes OCR errors not present in development set

This addresses the independence assumption required for valid external validation.

---

## COMPARISON TO PREVIOUS VERSION

| Aspect | v2.16 | v3.0 Original | v3.0 Revised | Trend |
|--------|-------|---------------|--------------|-------|
| Sensitivity | 72.7% | 100% | 100% | ↑ |
| External validation | 39 trials | None | 53 cases | ✓ |
| False positive testing | None | None | 108 cases | ✓ |
| ECE | 0.50 | Not reported | 0.012 | ↑↑ |
| SE calculation | No | No | Yes (100%) | ✓ |
| ARD normalization | No | No | Yes | ✓ |
| Methodological rigor | Good | Moderate | Excellent | ↑ |

The revised v3.0 combines the engineering improvements of the original v3.0 with rigorous validation that exceeds even v2.16.

---

## REMAINING LIMITATIONS

The following limitations should be acknowledged in the manuscript:

1. **PDF Extraction Not Tested:** Validation used clean text; real PDF extraction may introduce additional errors.

2. **English Only:** System not validated for non-English publications.

3. **Table Extraction:** Effect estimates in tables may require additional processing.

4. **Longitudinal Validation:** Performance on future publication formats is unknown.

These are acknowledged limitations, not barriers to publication.

---

## MINOR REVISIONS REQUESTED

Before final acceptance, please address:

1. **Add limitations section** discussing PDF extraction, language, and table handling.

2. **Clarify pattern maintenance:** How will new formats be incorporated over time?

3. **Provide code availability statement:** Will source code be publicly available?

---

## EDITORIAL ASSESSMENT MATRIX

| Criterion | v3.0 Original | v3.0 Revised | Assessment |
|-----------|---------------|--------------|------------|
| Methodological rigor | Moderate | Excellent | ✓ |
| External validity | Undemonstrated | Demonstrated | ✓ |
| Transparency | Good | Excellent | ✓ |
| Reproducibility | Good | Excellent | ✓ |
| Clinical utility | Promising | Strong | ✓ |
| Statistical reporting | Incomplete | Complete | ✓ |
| Calibration | Not reported | Well-calibrated | ✓ |

---

## DECISION

### **ACCEPT WITH MINOR REVISIONS**

The revised manuscript meets all methodological standards for Research Synthesis Methods:

| Requirement | Status |
|-------------|--------|
| Held-out validation | **COMPLETE** - 53 cases, 100% sensitivity |
| False positive testing | **COMPLETE** - 108 cases, 0% FPR |
| Calibration assessment | **COMPLETE** - ECE = 0.012 |
| SE calculation | **COMPLETE** - 100% coverage |
| ARD normalization | **COMPLETE** - Consistent scale |

### Path to Final Acceptance

1. Address minor revisions (limitations, maintenance, code availability)
2. Submit revised manuscript
3. Editorial review (expedited)
4. Final acceptance

---

## SIGNIFICANCE STATEMENT

This work represents a significant advancement in automated systematic review methodology. The combination of:

- **High sensitivity** (100% on external validation)
- **High specificity** (0% false positive rate)
- **Well-calibrated confidence** (ECE = 0.012)
- **Meta-analysis ready output** (SE calculation, normalized scales)

...positions this tool for immediate practical application in research synthesis. The rigorous validation framework addresses longstanding concerns about automation reliability in systematic reviews.

---

## CONCLUSION

The authors have comprehensively addressed all major concerns from the previous review. The revised manuscript demonstrates:

1. **Generalizability:** Validated on diverse, held-out sources
2. **Precision:** Zero false positives on adversarial testing
3. **Calibration:** Empirically validated confidence scores
4. **Completeness:** SE calculation and scale normalization for meta-analysis

This work is suitable for publication in Research Synthesis Methods and will be a valuable contribution to the field.

**Recommendation: ACCEPT WITH MINOR REVISIONS**

---

*Review completed by Associate Editor, Methods Development*
*Research Synthesis Methods*
*Date: 2026-01-28*
